کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2711472 | 1145038 | 2006 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
CBNPC stades IIIB
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: CBNPC stades IIIB CBNPC stades IIIB](/preview/png/2711472.png)
چکیده انگلیسی
The prognosis of locally advanced inoperable non-small cell lung cancer (NSCLC) remains poor despite the advances in treatment achieved in recent years. Currently the best therapeutic strategy relies on concurrent radiotherapy and chemotherapy. This treatment should be reserved for patients of good performance status. Oesophagitis represents the limiting toxicity. If possible chemotherapy should be administered in full dosage during radiotherapy with the aim of controlling micrometastases. Combined cisplatin-etoposide remains a standard regime and cisplatin-vinorelbine offers a good efficacy/toxicity ratio. The choice between induction chemotherapy and consolidation chemotherapy remains uncertain. The addition of docetaxel as consolidation after radio-chemotherapy seems to improve survival but the results need to be confirmed by a randomised phase III trial. Recent technological advances in radiotherapy allow optimisation of the dose, improved results and reduced toxicity. The place of targeted therapies in the management strategy of stage III NSCLC is under investigation.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revue des Maladies Respiratoires - Volume 23, Issue 5, Part 3, November 2006, Pages 54-60
Journal: Revue des Maladies Respiratoires - Volume 23, Issue 5, Part 3, November 2006, Pages 54-60
نویسندگان
P. Fournel,